• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FOREO, INC. BEAR 2 MICRO CURRENT; STIMULATOR, TRANSCUTANEOUS ELECTRICAL, AESTHETIC PURPOSES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FOREO, INC. BEAR 2 MICRO CURRENT; STIMULATOR, TRANSCUTANEOUS ELECTRICAL, AESTHETIC PURPOSES Back to Search Results
Health Effect - Clinical Codes Deformity/ Disfigurement (2360); Unspecified Tissue Injury (4559)
Date of Event 05/02/2024
Type of Reportable Event Serious Injury
Event or Problem Description
I used the foreo bear 2 device 2x as indicated on the r side of my face, as it was the side i felt needed more "toning".As a result i have deep hollows and sagging skin from subcutaneous fat loss, which foreo markets as "safe" and states on its product that it exercises muscles and does not cause permanent loss of subcutaneous fat in the face.I have photos to show before & after as well as the great discrepancy between the two sides of my face.I have permanent damage to my face.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BEAR 2 MICRO CURRENT
Common Device Name
STIMULATOR, TRANSCUTANEOUS ELECTRICAL, AESTHETIC PURPOSES
Manufacturer (Section D)
FOREO, INC.
MDR Report Key19373925
Report NumberMW5155226
Device Sequence Number19171616
Product Code NFO
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial
Report Date (Section B) 05/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date05/21/2024
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
BIOTIN.; MULTIVITAMIN.; TRAZADONE FOR SLEEP.; VITAMIN E.; VITAMIN K. ; VITAMINS.
Outcome Attributed to Adverse Event Other;
Patient Age55 YR
Patient SexFemale
Patient Weight56 KG
Patient EthnicityHispanic
Patient RaceWhite
-
-